Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Sept 2026 for Azenta, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William E. Martin III: trading record in brief
William E. Martin III discloses dealings in 2 companies, chiefly Maravai Lifesciences Holdings, Inc. and Azenta, Inc. Between 17 October 2022 and 14 September 2026, the trades on record add up to 8 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 16 September 2026, the filings show a share grant in Azenta, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William E. Martin III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
15,272 shares0CommonSEC:0001628280-26-062348:0
17,790 shares@ US$24.240.028% mcap100.0% of flowCommonSEC:0001949513-26-000008:0
986,194 sharesClass A Common StockSEC:0001823239-25-000052:0
160,981 shares@ US$4.5645.3% of flowClass A Common StockSEC:0001823239-25-000016:0
50,843 shares@ US$8.2924.6% of flowClass A Common StockSEC:0001823239-24-000102:0
758,415 sharesClass A Common StockSEC:0001823239-24-000016:0
66,197 shares@ US$7.5430.1% of flowClass A Common StockSEC:0001823239-23-000085:0
120,019 sharesClass A Common StockSEC:0000899243-22-033827:0
8 of 8 declarations
